Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Are Wall Street Analysts Predicting Zoetis Stock Will Climb or Sink?

With a market cap of $65.3 billion, Zoetis Inc. (ZTS) is a global leader in animal health, specializing in medicines, vaccines, diagnostics, and precision health solutions for both livestock and companion animals. The company serves veterinarians, livestock producers, and pet owners worldwide, with a diversified portfolio spanning vaccines, parasiticides, dermatology, anti-infectives, and advanced diagnostic services.

Shares of the Parsippany, New Jersey-based company have underperformed the broader market over the past 52 weeks. ZTS stock has decreased 19.6% over this time frame, while the broader S&P 500 Index ($SPX) has gained 19.6%. Moreover, Zoetis stock has dropped 8.6% on a YTD basis, compared to SPX's 8.7% rise.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.